ATLANTA, May 11, 2023 Femasys Inc. , a biomedical company aiming to meet women s needs by developing a suite of products and product candidates that include minimally invasive, in-office. | May 11, 2023
-Received regulatory approval for both FemaSeed® and FemCerv® products from Health Canada- ATLANTA, May 11, 2023 Femasys Inc. , a biomedical company aiming to meet women s needs. | May 11, 2023
Company builds out management team and continues to implement its clinical programs to advance much-needed technologies for women’s health ATLANTA, March 24, 2022 Femasys Inc. , a. | March 24, 2022